|
The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis.
Br J Haematol. 2006 Jul; 134(1):92-4.
Martini CH, Brandts A, de Bruijne EL, van Hylckama Vlieg A, Leebeek FW, Lisman T, Rosendaal FR. |
|
Antiplatelet and antileukocyte effects of cardiovascular, immunomodulatory and chemotherapeutic drugs.
Cardiovasc Hematol Agents Med Chem. 2006 Jul; 4(3):237-61.
Nosal, R. |
|
Insulin resistance and atherosclerosis.
J Clin Invest. 2006 Jul; 116(7):1813-22.
Semenkovich CF. |
|
Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
Blood Coagul Fibrinolysis. 2006 Jul; 17(5):347-352.
Sucak GT, Acar K, Sucak A, Kirazl S, Haznedar R. |
|
Effect of Cigarette Smoking on Nitric Oxide, Structural and Mechanical Properties of Mouse Arteries.
Am J Physiol Heart Circ Physiol. 2006 Jun; Epub ahead of print Jun
Guo X, Oldham MJ, Kleinman M, Phalen RF, Kassab GS. |
|
Hematologic disorders in critically ill patients.
Semin Respir Crit Care Med. 2006 Jun; 27(3):286-96.
Mercer KW, Gail Macik B, Williams ME. |
|
DNA damage and repair in atherosclerosis.
Cardiovasc Res. 2006 Mar; Epub ahead of print Feb
Mahmoudi M, Mercer J, Bennett M. |
|
Vascular risk factors in sudden hearing loss.
Thromb Haemost. 2006 Mar; 95(3):454-61.
Rudack C, Langer C, Stoll W, Rust S, Walter M. |
|
Update in the diagnosis and management of pulmonary vasculitis.
Chest. 2006 Feb; 129(2):452-65. Review Oct
Frankel SK, Cosgrove GP, Fischer A, Meehan RT, Brown KK. |
|
Identification of macrophage arginase I as a new candidate gene of atherosclerosis resistance.
Arterioscler Thromb Vasc Biol. 2006 Feb; 26(2):365-71. Epub 2005 Nov 10
Teupser D, Burkhardt R, Wilfert W, Haffner I, Nebendahl K, Thiery J. |
|
DNA microarray analysis for human congenital heart disease.
Cell Biochem Biophys. 2006 Ene; 44(1):1-9.
Sharma HS, Peters TH, Moorhouse MJ, van der Spek PJ, Bogers AJ. |
|
Novel ideas of gene therapy for atherosclerosis: modulation of cellular signal transduction of TGF-beta family.
Curr Pharm Des. 2006 Ene; 12(7):877-86. Review Dic
Ishisaki A, Matsuno H. |
|
Chemokines as potential therapeutic targets in atherosclerosis.
Curr Drug Targets. 2006 Ene; 7(1):13-27. Review Dic
Sheikine YA, Hansson GK. |
|
Hemorheological parameters as determinants of myocardial tissue hematocrit values.
Clin Hemorheol Microcirc. 2006 Ene; 35(1-2):45-50.
Baskurt OK, Yalcin O, Gungor F, Meiselman HJ. |
|
Viscosity, hemostasis and inflammation in atherosclerotic heart diseases.
Clin Hemorheol Microcirc. 2006 Ene; 35(1-2):67-73.
Kesmarky G, Feher G, Koltai K, Horvath B, Toth K. |
|
Development of 5-lipoxygenase inhibitors-lessons from cellular enzyme regulation.
Biochem Pharmacol. 2005 Ago; 70(3):327-33.
Werz O, Steinhilber D. |
|
Circulating markers of inflammation are related to carotid artery atherosclerosis.
Int Angiol. 2005 Mar; 24(1):43-51.
Larsson PT, Hallerstam S, Rosfors S, Wallen NH. |
|
Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C.
Circulation. 2004 Jul; 110(1):51-7. Epub 2004 Jun 21
Sanada S, Asanuma H, Tsukamoto O, Minamino T, Node K, Takashima S, Fukushima T, Ogai A, Shinozaki Y, Fujita M, Hirata A, Okuda H, Shimokawa H, Tomoike H, Hori M, Kitakaze M |
|
Regulation of cytosolic prostaglandin E synthase by phosphorylation.
Biochem J. 2004 Jul; 381((Pt 1)):59-69.
Kobayashi T, Nakatani Y, Tanioka T, Tsujimoto M, Nakajo S, Nakaya K, Murakami M, Kudo I. |
|
Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease.
Br J Haematol. 2004 Jul; 126(2):213-8.
Mannucci PM, Capoferri C, CancianiMT. |
